$OMDA

Cook Steven L. sold $422K of OMDA

Cook Steven L. (Chief Financial Officer) sold 16,842 shares of Omada Health, Inc. (OMDA) at an average of $25.03 ($25.01–$25.03, $0.42M total) across 2 trades over 2026-08-10 to 2026-08-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Aug 12, 2026, 8:48 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 12, 2026, 9:07 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale amount, share count, and the confirmation that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 framing makes it more consistent with routine selling than a fundamental change.

03

What to watch

The filing does not state tax, diversification, or personal liquidity needs; without those details, the market may over-interpret the sale size.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-12, covering sales dated 2026-08-10 to 2026-08-11

Background

The article is an SEC Form 4 insider transaction for Omada Health, Inc. (OMDA) by its CFO.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Steven L. sold about $421.5K of OMDA shares via a 10b5-1 plan across two open-market trades at ~$25.01-$25.03.

Expected impact

Low likelihood of a sustained price move solely from this filing; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The disclosure is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new operating, regulatory, or financial guidance.

Market effects

Minimal, as this is company-specific insider selling with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Insider sales can still coincide with private information, but the presence of a 10b5-1 plan reduces the informational edge.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction; CFO Steven L. Cook sold shares under a 10b5-1 plan.

  • Steven L. Cook

    Chief Financial Officer who executed the open-market sales disclosed in the Form 4.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch